Champions Oncology Inc Stock
Your prediction
Champions Oncology Inc Stock
Champions Oncology Inc took a tumble today and lost -€0.200 (-4.120%).
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Champions Oncology Inc | -4.120% | 3.097% | 0.000% | -0.427% | -3.320% | -50.426% | - |
Ardelyx Inc. | -2.180% | -12.086% | -15.475% | 35.391% | 4.706% | -16.524% | - |
Salarius Pharmaceuticals Inc. | 1.850% | 10.553% | -19.266% | -71.613% | -20.721% | -98.176% | -99.994% |
Evolus Inc | -1.830% | -7.627% | -15.504% | 39.744% | 16.578% | 15.344% | - |
News
3 Dividend Champions with room for dividend growth
The World Series champion Texas Rangers recently paid nice dividends for sports bettors. For stock investors, there's a different, more predictable group of dividend payers worth betting on — the
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
HACKENSACK, NJ / ACCESSWIRE / November 2, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology